Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of mOPV2 in Lithuania
NCT02582255Phase 4Completed
- Sponsor
- Fighting Infectious Diseases in Emerging Countries
- Start
- Nov 2015
- Primary completion
- Jul 2016
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 4 trial of Sabin OPV2 in poliomyelitis, sponsored by Fighting Infectious Diseases in Emerging Countries. Started Nov 2015; status: completed.
02
Drugs
Sabin OPV2
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT02582255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02582255.